AVGN7, a novel gene therapeutic for treating cancer cachexia

Ended Project Grant Awarded Last action

Award ID
R44CA221539
Recipient
Awarding agency
Obligated
$2,002,000

Award facts

Assistance listing
93.395 Cancer Treatment Research
Completion date
Originally
Place of performance
Maryland, USA

Award details come from USAspending.gov.

Transactions

Action Obligated Date
Amendment $0
Amendment $0
Amendment $134,809
Amendment $0
Amendment $1
Amendment $0
Amendment $660,235
Original award $1,206,955

Quick answers

Who received award R44CA221539?

R44CA221539 was awarded to Aavogen Inc. by National Cancer Institute (National Institutes of Health) on September 25, 2017.

How much is award R44CA221539 worth?

$2,002,000 has been obligated on R44CA221539.

On GovTribe

See this award's full record

  • Every transaction and subaward
  • The recipient's other awards and teaming partners
  • Similar grant awards
  • Ask GovTribe AI about this award